Vice President, Clinical Development & Chief Medical Officer

Frances Priddy, M.D., leads clinical evaluation of vaccines and antibodies to prevent diseases of global health significance, supervising a global team conducting clinical trials in Africa, the U.S., and Europe. In this role, she is responsible for clinical research and development strategy for all products, including trial design, clinical operations, data management and analysis, clinical quality assurance, and human subject protection. Priddy also supports IAVI’s epidemiology program in Africa.

Priddy has more than 15 years of experience in vaccine clinical development, and 25 years of experience in global health research. Before joining IAVI, she was medical director of the Emory Vaccine Center’s clinical trials site and principal investigator for several HIV vaccine and microbicide trials. She served as an assistant professor in the Division of Infectious Diseases, Emory University School of Medicine, and conducted research throughout Africa.

She holds B.A. from Brown University, an M.P.H. from the University of California, Berkeley, an M.D. from the University of California, San Francisco, is board-certified in internal medicine, and is a Fellow of the American College of Physicians.